{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "medicine:vascular:pathology:cholesterol-embolization:ce-001",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T04:58:00.000Z",
    "contributors": [
      "copilot"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "board_yield": "HIGH",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/cholesterol-embolization",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "Cholesterol Embolization Syndrome (Atheroembolism)",
    "definition": "Systemic embolic disease caused by spontaneous or iatrogenic release of cholesterol crystals from ulcerated atherosclerotic plaques, lodging in small and medium arterioles causing mechanical occlusion and inflammatory response. Often triggered by vascular procedures or anticoagulation.",
    "key_concepts": [
      {
        "term": "Pathophysiology",
        "description": "Cholesterol crystals dislodge from atherosclerotic plaques \u2192 travel distally \u2192 lodge in small arterioles (100-200 \u03bcm) \u2192 mechanical obstruction + foreign body inflammatory reaction \u2192 end-organ damage"
      },
      {
        "term": "Triggers",
        "description": "Vascular procedures (catheterization, angiography, surgery); anticoagulation/thrombolysis (exposes ulcerated plaque); spontaneous from unstable plaque"
      },
      {
        "term": "Classic Triad",
        "description": "Recent vascular procedure + livedo reticularis + acute renal failure. Onset typically 1-4 weeks after trigger (unlike contrast nephropathy at 48-72h)"
      },
      {
        "term": "Skin Manifestations",
        "description": "Blue toe syndrome (purple/blue toes with preserved pulses); livedo reticularis (mottled, lace-like pattern); gangrene; ulceration; often bilateral and affecting distal extremities"
      },
      {
        "term": "Renal Involvement",
        "description": "Progressive renal failure over weeks to months; may mimic contrast nephropathy but later onset and persistent; can require dialysis"
      },
      {
        "term": "Multi-organ Involvement",
        "description": "GI: abdominal pain, GI bleeding, pancreatitis; CNS: stroke, confusion; Retinal: Hollenhorst plaques (cholesterol crystals in retinal arteries); splenic infarcts"
      },
      {
        "term": "Laboratory Findings",
        "description": "Eosinophilia (60-80% of cases); elevated ESR/CRP; low complement; eosinophiluria; often normal or mildly elevated creatinine initially progressing over weeks"
      },
      {
        "term": "Diagnosis",
        "description": "Clinical suspicion + characteristic findings; skin biopsy shows cholesterol clefts in arterioles; fundoscopy for Hollenhorst plaques; no specific test"
      },
      {
        "term": "Contrast Nephropathy Distinction",
        "description": "CIN: onset 48-72h, usually reversible by 7-10 days; Cholesterol embolization: onset 1-4 weeks, progressive, persistent/irreversible"
      },
      {
        "term": "Treatment",
        "description": "Supportive care; avoid further vascular intervention if possible; statins (stabilize plaque); discontinue anticoagulation if possible; dialysis if needed; prognosis often poor"
      },
      {
        "term": "Prognosis",
        "description": "High morbidity and mortality (up to 80% 1-year mortality in severe cases); survivors often have chronic renal impairment; no proven therapy reverses process"
      }
    ],
    "clinical_features": {
      "snomed_codes": [
        "70715002",
        "22298006"
      ],
      "icd_10_codes": [
        "I75.0",
        "I75.01",
        "I75.02"
      ],
      "symptoms": [
        "Blue/purple toes",
        "Skin mottling",
        "Abdominal pain",
        "Renal failure"
      ],
      "signs": [
        "Blue toe syndrome",
        "Livedo reticularis",
        "Preserved distal pulses",
        "Hollenhorst plaques",
        "Digital gangrene"
      ],
      "risk_factors": [
        "Recent vascular procedure",
        "Anticoagulation/thrombolysis",
        "Extensive aortic atherosclerosis",
        "Male sex",
        "Advanced age"
      ]
    },
    "differential_diagnosis": [
      "Contrast-induced nephropathy",
      "Arterial embolism (large vessel)",
      "Vasculitis",
      "Thromboangiitis obliterans",
      "Warfarin-induced skin necrosis",
      "Antiphospholipid syndrome"
    ],
    "statement": "Cholesterol Embolization Syndrome (Atheroembolism) is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Cholesterol-Embolization that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Cholesterol Embolization Syndrome (Atheroembolism) helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Cholesterol Embolization Syndrome (Atheroembolism) include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Cholesterol Embolization Syndrome (Atheroembolism)."
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Cholesterol Embolization Syndrome"
    },
    "altLabel": [
      {
        "@language": "en",
        "@value": "Atheroembolism"
      },
      {
        "@language": "en",
        "@value": "Blue toe syndrome"
      },
      {
        "@language": "en",
        "@value": "Cholesterol crystal embolization"
      }
    ],
    "definition": {
      "@language": "en",
      "@value": "Systemic embolic disease caused by release of cholesterol crystals from ulcerated atherosclerotic plaques, lodging in small arterioles and causing end-organ damage"
    },
    "notation": "ce-001"
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "70715002",
      "uri": "http://snomed.info/id/70715002",
      "description": "Atheroembolism (disorder)"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "I75.0",
      "description": "Atheroembolism"
    }
  ],
  "relationships": {
    "skos:broader": [
      "medicine:vascular:pathology:atherosclerosis"
    ],
    "skos:related": [
      "medicine:vascular:pathology:bluetoe:bluetoe-001",
      "medicine:vascular:complications:contrast-nephropathy:cin-001",
      "medicine:nephrology:acute-kidney-injury"
    ],
    "skos:narrower": []
  },
  "pedagogical": {
    "learning_objectives": [
      "Define cholesterol embolization syndrome and identify triggers",
      "Recognize the classic triad (procedure + livedo + renal failure)",
      "Distinguish from contrast-induced nephropathy by timing",
      "Understand the poor prognosis and lack of specific treatment"
    ],
    "clinical_pearls": [
      "Blue toes with palpable pulses = cholesterol embolization",
      "Onset 1-4 weeks after procedure (CIN is 48-72 hours)",
      "Eosinophilia in 60-80% - helpful diagnostic clue",
      "Hollenhorst plaques on fundoscopy = retinal cholesterol emboli",
      "Mortality up to 80% in severe cases",
      "Statins help stabilize plaques - continue/start them"
    ],
    "common_mistakes": [
      "Attributing to contrast nephropathy (wrong timeline)",
      "Continuing anticoagulation (may worsen embolization)",
      "Missing the diagnosis (think of it after vascular procedures)",
      "Expecting renal recovery (often irreversible)"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Cholesterol Embolization Syndrome (Atheroembolism). Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}